Gulfstream Diagnostics stands at the forefront of toxicology and pharmacogenomics, exploring the relationship between genetics and drug metabolism. We believe pharmacogenomics can forever alter the shape of personalized medicine, as it gives doctors a much clearer understanding as to how a patient may react to certain drugs, and how at risk they may be to interactions between prescriptions.

Gulfstream Diagnostics’ state-of-the-art pharmacogenomics lab features QuantStudio™ Flex technology for the most comprehensive analyses possible. Focusing on toxicology services and UDT (Urine Drug Testing). We take pride in the quality of our services, our COLA Excellence Award-winning lab, and our commitment to providing innovative and insightful industry data. Patients deserve to know how their lives can be changed for the positive as a result of these emerging technologies, and health professionals deserve to know how to best serve them.

Our continuing goal is to foster healthy lifestyles and improve the health care industry.